Hi all
pretty new to all this. I have pumped some into Deltex - looks like a strong product with good growth. Could be a steady gainer.
Does anyone else have this, and anyone have some research on it? Someone with more experience than me!
thanks in advance.
Grajul

Mr John Christou recently purchased 500,000 shares. It appears someone has faith. Anyone know who he is.

No idea, doesn't appear to be on the board of directors @ DEMG.
2517

THE COUNT--->ALL

I made this post over on the dark side a little earlier if it helps.


Post as follows....

The Count - 19 May'06 - 10:29 - 450 of 474

THE COUNT--->ALL

Ok, I have had clarification from the company about the ill advised timing of yesterday's RNS.

I copy some of the email below.

To clarify a couple of points:

- this was an RNS REACH announcement, rather than RNS
- broker advice was that there was nothing new about this (i.e. we already know CardioQ good for patients & reduces stay) therefore REACH
- timing driven by an article appearing in the Edinburgh Evening Times yesterday evening (link below) and in anticipation of attached article from The Scotsman today; there was also coverage on BBC radio Scotland yesterday
- the whole point of this exercise is to unblock the sales pipeline in Scotland; doing that would/will generate a stream of strong RNS news
- the announcement was therefore timed to prevent any criticism if Scotsman readers made the link & started driving the price when other market participants did not have access to the same story
- NB the September 2004 Times article re the Medway was not printed in Scottish edition and was of limited value to us there; today's feature re-balances this.

Link to the article as follows....



Now, on reading that article, things do start to look very interesting indeed. I particularly like the '1m patients a year' reference.....errr, that's just here in the UK alone incidentally.

Let's do some basic sums to unearth the sort of potential we could be looking at here. 1m probes pa at 60 per probe gives us probe revenue of circa 60m pa. Now, conservatively speaking, at least 50% (should be a lot more) should flow through to the bottom line. So we are talking about potentially, 30m plus profits pa....IN THE UK alone!!!!! And we are currently trading on a market cap of only 14m.

Replicate this in other major economies around the world and the potential is absolutely staggering.

In case people want to go out and start buying this like there was no tomorrow (which I very much doubt at this point), this is still mainly about potential. We are currently the market leader in the UK and need to remain there to get a decent slug of this potential. We are dealing with highly bureaucratic, administrative and labour intensive nightmares when dealing with health services of all ilks.

The biggest task/hurdle though, and one we are rapidly overcoming, is persuading highly conservative and critical medical professionals (the doctors, surgeons, intensivists or whatever you wish to call them) of the benefits to their patients and to those that hold the purse strings of this technology. Of course, there will always be sceptics too, but the numbers of the 'converted' are slowly beginning to speak for themselves too and this is growing. And despite this growth, actual usage still lags current clinical demand by a factor of 10.

The dam is cracking....one day we hope it will break.

But the potential is all out there. Despite this being a slow process, I am as excited as ever about this company and this technology.

Regards,

THE COUNT!

PS. Here are another couple of links to go with the above.


www.eveningtimes.co.uk/hi/news/5052443.html

http://news.bbc.co.uk/1/hi/scotland/glasgow_and_west/4992140.stm

Good summing up. Cheers.

And the way the NHS see it is 60 extra per patient per probe, add this to the already troubled budget and Mr Gordon Brown isn't a happy bunny.

Currently the NHS do not want to process more patients than they are doing as it costs more money. If and when local GPs start taking some of the strain off the NHS they may have room for investment or further admin staff! As I've said before Deltex is one company waiting for its order books to fill, there are many others.

I agree that the NHS do not want to process more patients, and that is how I looked at the situation, but they have to show they are treating patients efficiently, ie cost effective. The problem is the more incompetent the management show they are, they employ even more managers to sort the mess out. But with many operations now being farmed out to private hospitals, keeping the cost down in these units is important as they are vying for each patient. Competition will win the day.

Greekman - You are correct competition will win the day. However I don't recall the private sector such as Bupa ever placing an order with Deltex. Now surely you'd expect adoption in the private sector before in the public!!

I agree. I have been unable to find any Private British hospital with the cardioQ. Plenty around the world though. Hopefully as more patients are farmed out ( I personally thing the NHS in it's present form has had its day ) to the private sector things will improve for Deltex. But as you say you would expect the private sector to get on board first.

If you also add to this the extreamily slow takeup in the states and within Europe it makes me wonder how long deltex can hold on.... I figure another share placing to raise funds and further dilute shareholder value will come before any such orderbook. I do agree the technology is amazing and results speak for itself making deltexs potential massive. End of the day though sales are needed if this business will suceed and for the past 3 years we've been awaiting a sniff of them.

The "Big Hope" came on 28th July 2004 when Former Chief Executive of UK NHS joined Deltex Medicals Board. Sir Duncan worked for the NHS for 30 years and was Chief Executive from 1989 to 1994, and executive director of Synergy Healthcare PLC and from 1994-2002 was a non-executive director of BUPA.

I for one expected to see Sir Duncan bring home the sales. Nearly 2 years later I have sold Deltex but have kept them on my watchlist awaiting the golden RNS stating contracts signed for "real" signifficant probe and CardioQ sales. Finally CardioQs patient, how long left to get sales and exploit the market before the technology is copied?

THE COUNT--->EXPLOSIVE

For someone who has absolutely no idea, you really do try to come across with a great deal of authority don't you?

The arguments are not quite as simple as you would try to portray.

THE COUNT!

The Count - Please do not even try and go there, lets hear your arguements and what ever kind of spin you'd like to put on this?

As for authority I have none, its a free world mate and a free BB for anyone wanting to post a view, ramper or deramper. All I've done is state the facts, happy to ammend my posts if you can prove me wrong!!

explosive,

Your post 209 hits the nail on the head. As you say take up is slow, although the cardioQ is being used ( albe'it in small quantities ) in quite a few countries.
I think the next 12 months or so will be make or break.

THE COUNT--->EXPLOSIVE

I'll make my further arguments when I am good and ready. I've argued with hundreds of idiots and know alls in the past so I'll pick and choose when, if you don't mind. I am not categorising you in that subset by the way, but many of your arguments are far too simplistic. Just because take up hasn't been immediate and to your shorter timeframes, it is still light years away from meaning that this business model is dead.

They are not as strapped for cash as you would imply, and the cash burn is improving all the time. Read the report in detail before you come out with simple assumptions off the top of your head.

I am preparing a detailed report covering most aspects of the company which I hope to post up hopefully in the next month or so. Hopefully, it might just answer a few of your concerns although it would seem you are not a shareholder so I wonder if you are basing your arguments oin the news at the time when you did hold.

Things move on. This is not static. We all have to be able to take news as it happens and act accordingly, I'm sure you'll agree. And your talk of extremely slow takeup both in the USA and in Europe further shows that you really only have a token understanding of what is at play here.

This is being taken up in the home country of haemodynamic optimisation, and the numbers of both supportive clinical trials and supportive clinicians are growing all the time, albeit slower than people expected a couple of years ago. But they are still growing.

I won't say more now as I would rather answer most concerns in the body of a larger report.

I don't spin. Looking back for a start, my arguments in my single post are not even remotely as simplistic and full of generalisations as yours. We can all sound knowledgable when we are the biggest fish in a little pond, but let's see how things go once a bigger fish or two enters the fray.

You are absolutely right. It is a free world and we all have opinions...but the real crux of the matter boils down to how informed our opinions are and how we draw reasoned analysis from that. You already betray your stance even before any reasoned argument is put your way by talking of the 'spin' I wil put on this. I am usually careful about what I say, and if I don't know enough about a subject, or very little, I tend to shut up rather than show myself up.

Have a good weekend.

THE COUNT!

Thanks Greekman, I agree the next 12 months will be make or break for this company. Will be interesting also to see if another fund raising placement occurs. Anyway good luck to all those holding, you never know I could be back in myself.

T

Greekman - Here here!!

The Count - Look forward to reading your in depth post. You called mine simplistic, generalised and a token understanding but didn't in anyway elaberate. I hope your report contains more useful information than your post 213 which contained none.

With the present climate of Director selling at 3 to 1 of Director buying, it's nice to see this confident announcement.

Ewan Phillips, Finance Director, has notified the
Company that he has today purchased 22,500 ordinary shares at a price of 20.00
pence per share.

Yeh.. good stuff ! let's hope we start to see some good product sales and results !

On todays news they highlighted how the number of NHS beds has been reduced over the last 10 years due to new methods, innovations etc. OK this may be ( and probably is ) yet another political stunt to make out all the ward closures are in order. It did show that the big push to reduce costs was to aim at patients spending less time in hospital. I think we could all give the NHS managers a push ( or should that be a kick ) in the right direction. I wonder if frustration is treated on the NHS.

The FD has bought 4.5K worth of shares, big deal. John Christou bought 1/2million and we have no idea who he is yet, he isn't on the B of D. Skyhigh is right, we need sales of the Cardio Q for the sp to rise, it's no good having a terrific product unless there are buyers for it.
2517